Generics 19

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Amiloride manufacturers

19 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

19 products found

amiloride

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20848

Manufacturer usually replies in 3 days

amiloride + hydrochlorothiazide

Tablets 5 mg+50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472

Manufacturer usually replies in 4 days

amiloride + hydrochlorothiazide

Tablets 2.5 mg + 25 mg, 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

amiloride

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

amiloride

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

amiloride + hydrochlorothiazide

Oral solution 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

amiloride + hydrochlorothiazide

Tablets 2.5 mg + 25 mg, 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

amiloride

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

amiloride + hydrochlorothiazide

Tablets for oral solution 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19884

Manufacturer usually replies in 6 days

amiloride + hydrochlorothiazide

Tablets for oral solution 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19936

Manufacturer usually replies in 7 days

amiloride + furosemide

Tablets 5 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722

Manufacturer usually replies in 7 days

amiloride + hydrochlorothiazide

Tablets 2.5 mg + 25 mg, 5 mg + 12 mg, 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722

Manufacturer usually replies in 7 days

amiloride + hydrochlorothiazide

Tablets 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21238

amiloride

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21238

amiloride

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19409

amiloride + hydrochlorothiazide

Tablets 5 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #32972

amiloride

Tablets 5 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Unavailable markets
United Kingdom
Comments
Dossier availability date: Q2 2024
Manufacturer #32970

furosemide + amiloride

Tablets 40 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

furosemide + amiloride

Tablets 40 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18649

AMILORIDE Manufacturers and Suppliers

We have found 15 verified amiloride manufacturers and amiloride suppliers from our global list of sellers. The pharmaceutical drug is available for sale in different forms such as tablets from manufacturers in various countries including European Union, India, Serbia, South Korea, Jordan.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of amiloride offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for amiloride manufacturers and amiloride suppliers that you are looking for. These also enable you to check the dossier status of amiloride, and the GMP approvals of the different variants of amiloride. Also, each manufacturer or supplier product description contains essential information about amiloride including clinical data, stability zones, countries where amiloride is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier lic, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over amiloride offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that amiloride manufacturers have, we qualify their companies before they are on-boarded on the platform. This allows us to screen amiloride manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.